Jefferies Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.5M Sell
642,123
-281,197
-30% -$7.36M 0.1% 181
2026
Q1
$25.9M Sell
923,320
-306,961
-25% -$8.17M 0.18% 94
2025
Q4
$30.6M Buy
1,230,281
+837,581
+213% +$21.1M 0.16% 122
2025
Q3
$10M Buy
392,700
+139,316
+55% +$3.44M 0.05% 239
2025
Q2
$6.14M Sell
253,384
-129,721
-34% -$3.03M 0.05% 252
2025
Q1
$9.71M Sell
383,105
-947,800
-71% -$24.8M 0.09% 159
2024
Q4
$35.3M Buy
1,330,905
+813,374
+157% +$22.1M 0.21% 83
2024
Q3
$15M Sell
517,531
-694,330
-57% -$20.3M 0.11% 120
2024
Q2
$33.9M Buy
1,211,861
+746,856
+161% +$20.6M 0.36% 43
2024
Q1
$12.9M Buy
465,005
+194,545
+72% +$5.4M 0.12% 133
2023
Q4
$7.79M Buy
270,460
+150,214
+125% +$4.54M 0.05% 278
2023
Q3
$3.99M Buy
120,246
+15,815
+15% +$559K 0.04% 400
2023
Q2
$3.83M Buy
104,431
+36,528
+54% +$1.42M 0.03% 423
2023
Q1
$2.77M Sell
67,903
-155,733
-70% -$6.73M 0.02% 550
2022
Q4
$11.5M Buy
+223,636
New +$10.7M 0.08% 201

Other funds holding PFE

Jefferies Financial Group's PFE Position: Q2 2026 in Review

Jefferies Financial Group reduced its Pfizer (PFE) stake by 30% in Q2 2026, selling an estimated $7.36M and leaving 642,123 shares worth $15.5M. The position accounts for 0.1% of the portfolio, ranked #181.

Jefferies Financial Group first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $35.3M in Q4 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Jefferies Financial Group held 642,123 shares of Pfizer worth $15.5M as of Q2 2026.
  • Jefferies Financial Group sold 281,197 Pfizer shares in Q2 2026, an estimated $7.36M.
  • Pfizer made up 0.1% of Jefferies Financial Group's portfolio in Q2 2026, its #181 holding.
  • Jefferies Financial Group first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
  • Jefferies Financial Group's Pfizer position peaked at $35.3M in Q4 2024.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.